These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
363 related articles for article (PubMed ID: 2527934)
1. Red blood cell calcium homeostasis in patients with end-stage renal disease. Gafter U; Malachi T; Barak H; Djaldetti M; Levi J J Lab Clin Med; 1989 Sep; 114(3):222-31. PubMed ID: 2527934 [TBL] [Abstract][Full Text] [Related]
2. Red blood cell calcium level in chronic renal failure: effect of continuous ambulatory peritoneal dialysis. Gafter U; Malachi T; Barak H; Levi J J Lab Clin Med; 1990 Sep; 116(3):386-92. PubMed ID: 2144869 [TBL] [Abstract][Full Text] [Related]
3. Red blood cell calcium level is elevated in women: enhanced calcium influx by estrogens. Gafter U; Malachi T; Barak H; Levi J J Lab Clin Med; 1993 Mar; 121(3):486-92. PubMed ID: 8445297 [TBL] [Abstract][Full Text] [Related]
4. Effect of end-stage renal disease on responsiveness to calmodulin and thyroid hormone of calcium-ATPase in human red blood cells. Nieman LK; Davis FB; Davis PJ; Cunningham EE; Gutman S; Blas SD; Schoenl M Kidney Int Suppl; 1983 Dec; 16():S167-70. PubMed ID: 6234422 [TBL] [Abstract][Full Text] [Related]
5. [Changes in RBC Ca2(+)-ATPase activity and red-cell calcium concentration during dialysis in patients with uremia]. Yang Y Zhonghua Yi Xue Za Zhi; 1990 Jan; 70(1):23-5, 4. PubMed ID: 2157534 [TBL] [Abstract][Full Text] [Related]
6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
7. Erythrocyte susceptibility to oxidative stress in chronic renal failure patients under different substitutive treatments. Lucchi L; Bergamini S; Iannone A; Perrone S; Stipo L; Olmeda F; Caruso F; Tomasi A; Albertazzi A Artif Organs; 2005 Jan; 29(1):67-72. PubMed ID: 15644086 [TBL] [Abstract][Full Text] [Related]
9. Plasma amino acid profile and L-arginine uptake in red blood cells from malnourished uremic patients. Reis PF; da Silva CD; Brunini TM; Moss MB; Siqueira MA; Santos SF; Roberts NB; Ellory JC; Mann GE; Mendes-Ribeiro AC J Ren Nutr; 2006 Oct; 16(4):325-31. PubMed ID: 17046616 [TBL] [Abstract][Full Text] [Related]
10. Alterations in cellular calcium handling as a result of systemic calcium deficiency in the developing chick embryo: I. Erythrocytes. Koide M; Smith CA; Miyahara T; Tuan RS J Cell Physiol; 1992 Dec; 153(3):626-35. PubMed ID: 1447322 [TBL] [Abstract][Full Text] [Related]
11. Effects of erythropoietin and aminoguanidine on red blood cell deformability in diabetic azotemic and uremic patients. Brown CD; Zhao ZH; Thomas LL; deGroof R; Friedman EA Am J Kidney Dis; 2001 Dec; 38(6):1414-20. PubMed ID: 11728984 [TBL] [Abstract][Full Text] [Related]
12. [Evaluation of the factor which has an influence on red blood cell deformability in patients with end-stage renal disease]. Tateishi K; Fujita J; Taminato T Rinsho Byori; 2009 Oct; 57(10):965-70. PubMed ID: 19928493 [TBL] [Abstract][Full Text] [Related]
13. Mechanisms of uremic erythrocyte-induced adhesion of human monocytes to cultured endothelial cells. Pandolfi A; Di Pietro N; Sirolli V; Giardinelli A; Di Silvestre S; Amoroso L; Di Tomo P; Capani F; Consoli A; Bonomini M J Cell Physiol; 2007 Dec; 213(3):699-709. PubMed ID: 17516566 [TBL] [Abstract][Full Text] [Related]
14. Oxidative stress, sister chromatid exchanges and apoptosis in the pathogenesis of lymphocytopenia in ESRD patients. Pernice F; Floccari F; Nostro L; Caccamo C; Belghity N; Mantuano S; Romeo A; Barilla' A; Aloisi C; Ruello A; Frisina N; Buemi M J Nephrol; 2006; 19(5):613-20. PubMed ID: 17136690 [TBL] [Abstract][Full Text] [Related]
15. Loss of phospholipids asymmetry in red blood cells contributes to anemia in uremic patients. Kong QY; Wu X; Li J; Peng WX; Ye R; Lindholm B; Wang T Adv Perit Dial; 2001; 17():58-60. PubMed ID: 11510298 [TBL] [Abstract][Full Text] [Related]
16. Decreased bioavailability of insulin-like growth factor-I, a cause of catabolism in hemodialysis patients? Lindgren BF; Odar-Cederlöf I; Ericsson F; Brismar K Growth Regul; 1996 Sep; 6(3):137-43. PubMed ID: 8894646 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of ouabain-insensitive red blood cell cation transport in uremic patients. Boero R; Quarello F; Guarena C; Piccoli G Boll Soc Ital Biol Sper; 1985 Feb; 61(2):243-8. PubMed ID: 3994843 [TBL] [Abstract][Full Text] [Related]
18. Red blood cell survival in chronic renal failure. Ly J; Marticorena R; Donnelly S Am J Kidney Dis; 2004 Oct; 44(4):715-9. PubMed ID: 15384023 [TBL] [Abstract][Full Text] [Related]
19. Determinants of soluble CD23 antigen levels in hemodialysis patients: effect of 1.25 dihydroxyvitamin D3 and recombinant human erythropoietin treatment. Altun B; Erdem Y; Usalan C; Arici M; Haznedaroglu IC; Yasavul U; Turgan C; Caglar S; Kirazli S Clin Nephrol; 1999 Oct; 52(4):230-8. PubMed ID: 10543325 [TBL] [Abstract][Full Text] [Related]
20. Nitric oxide synthetic pathway and cGMP levels are altered in red blood cells from end-stage renal disease patients. Di Pietro N; Giardinelli A; Sirolli V; Riganti C; Di Tomo P; Gazzano E; Di Silvestre S; Panknin C; Cortese-Krott MM; Csonka C; Kelm M; Ferdinandy P; Bonomini M; Pandolfi A Mol Cell Biochem; 2016 Jun; 417(1-2):155-67. PubMed ID: 27206740 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]